Post by account_disabled on Dec 28, 2023 1:51:23 GMT -7
Marta Moreno is the new director of Corporate Affairs and Market Access at AstraZeneca Spain , as the company announced in a statement. The professional will be in charge of leading the company's corporate strategy, the management of the AstraZeneca Foundation and the Communication and Corporate Social Responsibility area , which will become part of this team, starting in February. Marta Moreno takes over from Luis Cordero , who until now held the position and who will now assume the new role of Global Market Access Vaccine Director (EU) as part of the Global Market Access and Price team. «Being part of the AstraZeneca team in an unprecedented time like the current one is a great source of pride for me. As head of Corporate Affairs and Market Access, I will continue working to facilitate and expedite the arrival of the best scientific advances , stimulate innovation and accelerate the development of medicines that respond to medical needs and provide value to patients who need them," says Marta.
Dark. For his part, Rick Suárez, president of AstraZeneca Spain, points out that "this incorporation demonstrates AstraZeneca's commitment to continue growing through innovation ." Marta Moreno's strategic vision Phone Number List and negotiating skills will bring us new ways of working in the company and will contribute to improving the sustainability of our health system, one of our priority objectives. Marta Moreno's career Marta Moreno has a degree in Pharmacy from the University of Alcalá de Henares and has a Master's degree in Health Policy, in addition to other business management training in Healtheconomics and people management. Marta Moreno has a professional career of more than 20 years in the pharmaceutical industry , where she has worked in departments such as sales, marketing, medical, market access and institutional relations. In the latter she has nearly 15 years of experience.
Moreno has also worked on the European pricing strategy , being part of the European Pricing & Reimbursement and Market Access & Pricing & Public Affairs European Board teams in other pharmaceutical companies. After 16 years at Janssen , he held the role of Head of Pricing for the last 5 years and in 2016, he joined Celgene as Market Access & Regulatory Affairs Director. Until joining AstraZeneca Spain, Moreno worked for the Novartis Oncology team as director of the market access department, where she obtained approval of the first Cart Cell Therapy through the first payment agreement for health results at the national level. In early 2020 she was named Country Head of Public Affairs Novartis Group and Market Access Novartis Oncology.
Dark. For his part, Rick Suárez, president of AstraZeneca Spain, points out that "this incorporation demonstrates AstraZeneca's commitment to continue growing through innovation ." Marta Moreno's strategic vision Phone Number List and negotiating skills will bring us new ways of working in the company and will contribute to improving the sustainability of our health system, one of our priority objectives. Marta Moreno's career Marta Moreno has a degree in Pharmacy from the University of Alcalá de Henares and has a Master's degree in Health Policy, in addition to other business management training in Healtheconomics and people management. Marta Moreno has a professional career of more than 20 years in the pharmaceutical industry , where she has worked in departments such as sales, marketing, medical, market access and institutional relations. In the latter she has nearly 15 years of experience.
Moreno has also worked on the European pricing strategy , being part of the European Pricing & Reimbursement and Market Access & Pricing & Public Affairs European Board teams in other pharmaceutical companies. After 16 years at Janssen , he held the role of Head of Pricing for the last 5 years and in 2016, he joined Celgene as Market Access & Regulatory Affairs Director. Until joining AstraZeneca Spain, Moreno worked for the Novartis Oncology team as director of the market access department, where she obtained approval of the first Cart Cell Therapy through the first payment agreement for health results at the national level. In early 2020 she was named Country Head of Public Affairs Novartis Group and Market Access Novartis Oncology.